Vendor, Solon, OH
CMC Pharmaceuticals, Inc.
UEI R9AVS7XL2YB4, CAGE 7UJR5
1 award and $431,622 obligated between May 15, 2024 and May 15, 2024, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $431,622 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| W911SR23C0019Definitive Contract, May 15, 2024, Full and Open Competition After Exclusion of Sources, 1 offers | W6QK ACC-APGDepartment of the Army | Modification P00002 Exercises Optional Contract Line Item 0002 for Continued Research of Pharmaceutical Development, Planning, and Cmo IdentNAICS 541715, PSC AC12 | $431,622 |
- Places of performance
- Ohio
- Product and service codes
- AC12 National Defense R&D Services; Department Of Defense - Military; Applied Research
- Transactions
- 1 across 1 awards